Health
Neanderthal-derived protein may reduce the severity of COVID-19 – Medical Xpress
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced…
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes. The findings are published today in Nature Medicine.
“Our analysis shows evidence that OAS1 has a protective effect against COVID-19 susceptibility and severity,” explains…
-
Noosa News15 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General16 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General14 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
Noosa News17 hours agoThe Best Things to Do in Brisbane This New Year’s Eve